Edaravone suppresses degradation of type II collagen

Biochemical and Biophysical Research Communications

Volumn 473, Issue 4, 2016, Pages 840-844

  Huang, Chen ^a   Liao, Guangjun ^a   Han, Jian ^a   Zhang, Guofeng ^a   Zou, Benguo ^a  

^a YANTAISHAN HOSPITAL   (China)

Author keywords

Collagen; Edaravone; IRF 1; MMP 13; Osteoarthritis (OA); Type II

Indexed keywords

COLLAGEN TYPE 2; COLLAGENASE 3; INTERFERON REGULATORY FACTOR 1; NORPHENAZONE; STAT1 PROTEIN; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; PHENAZONE; PHENYLMETHYLPYRAZOLONE; SCAVENGER; TUMOR NECROSIS FACTOR;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL PROTECTION; COLLAGEN DEGRADATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANALOGS AND DERIVATIVES; CELL CULTURE; CHONDROCYTE; DOSE RESPONSE; DRUG EFFECTS; ENZYME ACTIVATION; METABOLISM;

ANTIPYRINE; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FREE RADICAL SCAVENGERS; HUMANS; MATRIX METALLOPROTEINASE 13; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84964322261     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.03.136     Document Type: Article

References (16)

1. R.C. Lawrence, D.T. Felson, C.G. Helmick, L.M. Arnold, H. Choi, R.A. Deyo, and et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States Part II. Arthritis Rheum. 58 2008 26 35
2. M.J. Lammi Current perspectives on cartilage and chondrocyte mechanobiology Biorheology 41 2004 593 596
3. A.R. Poole, M. Kobayashi, T. Yasuda, and et al. Type II collagen degradation and its regulation in articular cartilage in osteoarthritis Ann. Rheum. Dis. 61 2002 ii78 ii81
4. M.P. Vincenti, and C.E. Brinckerhoff Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors Arthritis Res. 4 2002 157 164
5. Study-Group E Effect of a novel free radical scavenger, Edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters Cerebrovasc. Dis. 15 2003 222 229
6. S. Abe, K. Kirima, K. Tsuchiya, and et al. The reaction rate of edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186)) with hydroxyl radical Chem. Pharm. Bull. (Tokyo) 52 2004 186 191
7. T. Watanabe, S. Yuki, M. Egawa, and H. Nishi Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions J. Pharmacol. Exp. Ther. 268 1994 1597 1604
8. S. Onimaru, K. Nakamura, H. Kariyazono, R. Ikeda, T. Ueno, Y. Fukumoto, A. Yabuki, R. Sakata, and K. Yamada Inhibitory effects of edaravone on the production of tumor necrosis factor-α in the isolated heart undergoing ischemia and reperfusion Heart Vessels 21 2006 108 115
9. K. Isahaya, K. Yamada, M. Yamatoku, and et al. Effects of edaravone, a free radical scavenger, on serum levels of inflammatory biomarkers in acute brain infarction J. Stroke Cerebrovasc. Dis. 21 2012 102 107
10. B. Sheng, X. Wang, B. Su, and et al. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease J. Neurochem. 120 2012 419 429
11. S.L. Bevill, K.A. Boyer, and T.P. Andriacchi The regional sensitivity of chondrocyte gene expression to coactive mechanical load and exogenous TNF-α stimuli J. Biomech. Eng. 136 2014 091005
12. F.R. Weiner, A. Shah, P.J. Smith, C.S. Rubin, and M.A. Zern Regulation of collagen gene expression in 3T3-L1 cells. Effects of adipocyte differentiation and tumor necrosis factor alpha Biochemistry 28 1989 4094 4099
13. C. Melchiorri, R. Meliconi, L. Frizziero, T. Silvestri, L. Pulsatelli, I. Mazzetti, and et al. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis Arthritis Rheum. 41 1998 2165 2174
14. H.I. Roach, N. Yamada, K.S. Cheung, S. Tilley, N.M. Clarke, R.O. Oreffo, and et al. Association between the abnormal expression of matrix degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions Arthritis Rheum. 52 2005 3110 3124
15. H. Lu, C. Zeng, H. Zhao, L. Lian, and Y. Dai Glatiramer acetate inhibits degradation of collagen II by suppressing the activity of interferon regulatory factor-1 Biochem. Biophys. Res. Commun. 448 2014 323 328
16. I.T. Nizamutdinova, Y.M. Kim, H. Jin, K.H. Son, J.H. Lee, K.C. Chang, and et al. Tanshinone IIA inhibits TNF-α-mediated induction of VCAM-1 but not ICAM-1 through the regulation of GATA-6 and IRF-1 Int. Immunopharmacol. 14 2012 650 657